A Single-Centre, Open Label, Single-Dose, Four Parallel Cohorts Study to Investigate the Pharmacokinetics, Safety and Tolerability of SB-649868 [GSK-649868] 10mg in Healthy Female 'Non-Childbearing Potential', Healthy Male and in Healthy Elderly Subjects.

Trial Profile

A Single-Centre, Open Label, Single-Dose, Four Parallel Cohorts Study to Investigate the Pharmacokinetics, Safety and Tolerability of SB-649868 [GSK-649868] 10mg in Healthy Female 'Non-Childbearing Potential', Healthy Male and in Healthy Elderly Subjects.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2015

At a glance

  • Drugs GSK 649868 (Primary)
  • Indications Insomnia
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 Jun 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 01 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top